Received Aug 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 1 | Y014323 | — |
No additional AEs were reported; Nurse reported that a patient received first dose of RECOMBIVAX on 2/5/2025 and the patient is in the office to received the second dose today. The patient did not receive the second dose yet; This spontaneous report was received from an other health professional and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. 05-FEB-2025, the patient was vaccinated with the first dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), lot #Y014323, expiration date reported as 12-Feb-2027 (strength, dose, route of administration and anatomical location of vaccine) for Prophylaxis. 12-AUG-2025, Nurse reported that a patient went to the office to receive the second dose today. The patient did not receive the second dose yet. The patient experienced No additional adverse event (AEs) were reported.